Patents by Inventor Sanne Moller Knudsen

Sanne Moller Knudsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Counteracting drug-induced obesity using GLP-1 agonists
    Patent number: 8410047
    Abstract: The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
    Type: Grant
    Filed: May 31, 2005
    Date of Patent: April 2, 2013
    Assignee: Novo Nordisk A/S
    Inventors: Camilla Bock, Sanne Møller Knudsen, Karin Rimvall
  • Long-Acting Y2 and/or Y4 Receptor Agonists
    Publication number: 20110275559
    Abstract: The present invention relates to a PYY or PP peptide derivative or analogue thereof derivatised with one or more serum albumin binding side chains comprising a dis-tal tetrazole or carboxylic acid group. Moreover, the invention relates to compositions hereof and methods of treatment of conditions responsive to Y receptor modulation.
    Type: Application
    Filed: May 18, 2009
    Publication date: November 10, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Søren Østergaard, Sanne Møller Knudsen, Jane Spetzler, Rasmus Jørgensen, Jacob Kofoed
  • Counteracting Drug-Induced Obesity Using GLP-1 Agonists
    Publication number: 20090054315
    Abstract: The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
    Type: Application
    Filed: May 31, 2005
    Publication date: February 26, 2009
    Applicant: NOVO VORDISK A/S
    Inventors: Camilla Bock, Sanne Moller Knudsen, Karin Rimvall
  • Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists
    Publication number: 20080275066
    Abstract: The invention provides compounds of formula (I) for use as GLP-1 receptor agonists.
    Type: Application
    Filed: June 21, 2005
    Publication date: November 6, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Sanne Moller Knudsen, Ingrid Pettersson, Jesper Lau, Carsten Behrens, Anders Klarskov Petersen, Jesper Lau, Patrick William Garibay
  • Method of identifying compounds capable of acting as agonists or antagonists of G-protein coupled receptors
    Publication number: 20020123071
    Abstract: The present invention relates to a method for identifying compounds capable of affecting the activity of G-protein coupled receptors (GPCRs), i.e. identifying agonists or antagonists of said receptor type. Such compounds are later useful e.g. as drugs or as leads in drug development. More specifically, if agonists are desired, the method comprises contacting a test compound with cell membrane from a GPCR expressing cell line, a kinase, such as G-protein coupled receptor kinase (GRK), and arrestin. If the test compound is an agonist it will allow said arrestin to bind to activated and phosphorylated GPCR. The above mentioned mixture is then contacted with carrier material capable of binding GPCRs, and signals are detected as an indication that the test compound is capable of acting as an agonist of GPCR.
    Type: Application
    Filed: December 4, 2001
    Publication date: September 5, 2002
    Inventors: Sanne Moller Knudsen, Fritz Poulsen, Anders Heding